Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
3
×
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
3
×
cell therapy
3
×
clinical trials
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
bristol-myers squibb
deals
diagnostics
drug prices
gene therapy
generic drugs
immunotherapy
investing
medicare
merck
What
bio
3
×
roundup
drug
new
advantages
ahead
approval
asco
bar
biogen’s
biopharmaceutical
branded
brings
choices
commissioner
companies
consumers
convo
costly
counterweight
drugs
earlier
elevatebio
expect
failures
fda
gamble
generic
graft
littered
market
medco’s
medications
mover
nash
news
patients
payers
physicians
plan
Language
unset
Current search:
photo
×
" cell therapy "
×
bio
×
cancer
×
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
5 years ago
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More